Clinical trial
Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor…
NCT00334945 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00334945 |
|---|---|
| Title | Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent |
| Official title | Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23 (a Known Phosphaturic Agent) |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Growth Disorders |
| Enrollment | 35 |
| Start date | Apr 1, 2006 |
| Primary completion | Jun 1, 2010 |
| Completion | Aug 1, 2011 |
| First posted | Jun 8, 2006 |
| Last update posted | Nov 16, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: